Brain Neoplasms: Clinical Trials

54 trials for Brain Neoplasms, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

30 completed, 9 unknown, 6 recruiting, 4 terminated. 54 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 454Completed 30, Unknown 9, Recruiting 6, Terminated 4, Active not recruiting 2, Enrolling by invitation 2, Withdrawn 1

Follow Brain Neoplasms: new trials by email Literature Review of Brain Neoplasms trials Research Report on Brain Neoplasms

Trials (filtered) newest first · largest first

All 54 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Evaluation of the Efficacy of STRATAFIX for Neurosurgical Cranial and Spine Procedures
STRATAFIX PDS and Monocryl suture - Wound Closure, Brain Tumor Adult
Phase 4RecruitingUniversity of Michigan1602025-11-012025-11-05
Comparison of Systemic Opioid (Morphine) and Pre-Incision Bilateral Scalp Nerve Block for Pain Management in Craniotomy Patients
Scalp nerve block, Morphine, Lidocaine - Supratentorial Tumors
Phase 4CompletedAga Khan University622025-01-012026-02-23
Hydrocortisone in Hormone Replacement Therapy for Large Pituitary Neuroendocrine Tumors
Hormone replacement therapy, Placebo - Pituitary Adenoma, Pituitary Neuroendocrine Tumor
Phase 4RecruitingBeijing Tiantan Hospital8822024-12-042025-01-14
Lorlatinib in Patients With ALK-Positive NSCLC With Brain or Leptomeningeal Metastases
Lorlatinib - Carcinoma, Non-Small-Cell Lung, Brain Metastases
Phase 4Active not recruitingGuangdong Association of Clinical Trials412024-08-012026-04-09
Cabergoline in the Management of Nonfunctioning Pituitary Adenoma
Cabergoline 0.5 MG - Pituitary Adenoma, MRI
Phase 4Enrolling by invitationNational Taiwan University Hospital302024-05-202025-06-24
Brain [18F]-FES PET/CT in Patients With Estrogen-Receptor Positive Breast Cancer
Brain Imaging with 18F-FES - Breast Cancer, Brain Metastases
Phase 4RecruitingWeill Medical College of Cornell University202023-12-272026-10-29
The Effects of Using Different Anesthetics on the Prognosis of Primary Tumors and Its Mechanism of Action
Propofol, Sevoflurane - Lung Cancer, Brain Tumor
Phase 4UnknownKaohsiung Medical University Chung-Ho Memorial Hospital13162023-05-232023-09-28
Comparison of Postoperative Recovery of Sevoflurane and Propofol After Transsphenoidal Surgery
sevoflurane, propofol - Pituitary Adenoma
Phase 4CompletedPeking Union Medical College Hospital2522023-05-032025-06-08
An Investigational Scan (64Cu-DOTA-Trastuzumab PET/MRI) in Imaging Patients With HER2+ Breast Cancer With Brain Metastasis
Copper Cu 64-DOTA-Trastuzumab, Magnetic Resonance Imaging, Positron Emission Tomography - Anatomic Stage IV Breast Cancer AJCC v8, Metastatic Breast Carcinoma
Phase 4RecruitingCity of Hope Medical Center102022-12-212026-07-01
Influences of Propofol and Sevoflurane Anesthesia in Brain Tumor
Propofol, Sevoflurane - Brain Tumor
Phase 4UnknownKaohsiung Medical University Chung-Ho Memorial Hospital7062022-02-182023-10-31
Infraorbital Nerve Block for Endoscopic Transsphenoidal Approach to Remove Pituitary Tumor
dexmedetomidine 5 mcg mixed with 0.5% plain bupivacaine - Intraoperative Pain Control
Phase 4UnknownChiang Mai University632021-07-012021-03-05
Dexmedetomidine Infusion Effect on Hemodynamic Variables During Craniotomy
Dexmedetomidine, normal saline - Hemodynamic Instability, Supratentorial Neoplasms
Phase 4CompletedAin Shams University402020-11-212021-03-01
Effect of Sugammadex for Reversal of Rocuronium-induced Neuromuscular Block on Perioperative Management of Awake Craniotomy
sugammadex - Brain Tumors
Phase 4UnknownGuangzhou General Hospital of Guangzhou Military Command402020-09-012022-03-09
Effect of Dexmedetomidine on Brain Homeostasis and Neurocognitive Outcome
Dexmedetomidine, Normal saline - Brain Tumor, Metabolic Disturbance
Phase 4CompletedGeorgia Tsaousi562020-03-122026-03-25
Pediatric Long-Term Follow-up and Rollover Study
dabrafenib, trametinib - Diffuse Astrocytoma, Anaplastic Astrocytoma
Phase 4Active not recruitingNovartis Pharmaceuticals1632019-11-042026-08-27
68-Ga DOTATATE PET/MRI in the Diagnosis and Management of Somatostatin Receptor Positive CNS Tumors.
Ga68-DOTATATE-PET/MRI - CNS Tumors, Meningioma
Phase 4RecruitingWeill Medical College of Cornell University2002019-09-042026-10-30
Dual Time Point FDG PET/MRI Scan in Improving the Imaging Cancer Patients With Brain Metastases
Fludeoxyglucose F-18, Magnetic Resonance Imaging, Positron Emission Tomography - Metastatic Malignant Neoplasm in the Brain, Metastatic Malignant Solid Neoplasm
Phase 4CompletedM.D. Anderson Cancer Center122018-08-032024-05-01
The Effect of Local Anesthesia on Postopanalgesia in Patients Using Head Holder
lidocaine was administered subcutaneously at 0.5% concentration., lidocaine was administered subcutaneously at 1% concentration. - Postoperative Pain, Acute
Phase 4CompletedKocaeli University752018-01-102026-06-05
Prophylactic Oral Antibiotics on Sinonasal Outcomes Following Endoscopic Transsphenoidal Surgery for Pituitary Lesions
Placebo, Oral Antibiotics cefdinir or trimethoprim/sulfamethoxazole - Antibiotics, Pituitary Adenoma
Phase 4RecruitingSt. Joseph's Hospital and Medical Center, Phoenix1162017-07-012018-08-15
Comparison of Efficacy and Safety of the Postoperative Analgesia Methods
Morphine, Dexketoprofen, Placebo - Supratentorial Neoplasms
Phase 4UnknownIstanbul University902016-11-012016-10-11

Showing 20 of 54. Sign in to see all of them.

Narrower conditions

Pituitary Neoplasms (16)  ·  Acromegaly (4)  ·  Supratentorial Neoplasms (4)  ·  Breast Neoplasms (3)  ·  Epilepsy (3)  ·  Melanoma (3)  ·  Neoplasm Metastasis (3)  ·  Glioblastoma (2)  ·  Lung Neoplasms (2)  ·  Neuroblastoma (2)  ·  Ovarian Neoplasms (2)  ·  Seizures (2)  ·  Astrocytoma (1)  ·  Brain Concussion (1)

Broader conditions

Brain Diseases (54)  ·  Central Nervous System Diseases (54)  ·  Neoplasms by Site (54)  ·  Nervous System Diseases (54)  ·  Nervous System Neoplasms (54)  ·  Central Nervous System Neoplasms (53)  ·  Neoplasms (53)  ·  Endocrine Gland Neoplasms (18)  ·  Endocrine System Diseases (18)  ·  Hypothalamic Diseases (16)  ·  Hypothalamic Neoplasms (16)  ·  Supratentorial Neoplasms (16)  ·  Pituitary Diseases (15)  ·  Pathological Conditions, Signs and Symptoms (10)

Interventions

Saline Solution (7)  ·  Dexmedetomidine (6)  ·  Propofol (4)  ·  Cabergoline (3)  ·  Morphine (3)  ·  Sevoflurane (3)  ·  Sodium Chloride (3)  ·  Anesthesia, Inhalation (2)  ·  Fluorescein (2)  ·  Levetiracetam (2)  ·  Magnetic Resonance Spectroscopy (2)  ·  Sugammadex (2)  ·  dexketoprofen trometamol (2)  ·  64Cu-DOTA-trastuzumab (1)  ·  Acetaminophen (1)

Sponsors

Aga Khan University (2)  ·  Chiang Mai University (2)  ·  Istanbul University (2)  ·  Kaohsiung Medical University Chung-Ho Memorial Hospital (2)  ·  M.D. Anderson Cancer Center (2)  ·  Mahidol University (2)  ·  NYU Langone Health (2)  ·  Novartis Pharmaceuticals (2)  ·  St. Joseph's Hospital and Medical Center, Phoenix (2)  ·  Weill Medical College of Cornell University (2)  ·  AdventHealth (1)  ·  Ain Shams University (1)  ·  Baskent University (1)  ·  Beijing Tiantan Hospital (1)  ·  Bracco Diagnostics, Inc (1)

Countries

United States (25)  ·  China (6)  ·  Turkey (Türkiye) (5)  ·  Germany (4)  ·  Taiwan (4)  ·  Thailand (4)  ·  Argentina (3)  ·  Italy (3)  ·  South Korea (3)  ·  Belgium (2)  ·  Brazil (2)  ·  Canada (2)  ·  Denmark (2)  ·  France (2)  ·  Greece (2)

Top investigators

Zhi-Fu Wu (2)  ·  Aaron A Cohen, MD, MSc (1)  ·  Alejandro D Muggeri, Physician (1)  ·  Alex Bekker, MD, PhD (1)  ·  Andrew Little, MD (1)  ·  Andrew S Little, MD (1)  ·  Anita Mahajan, MD (1)  ·  Annamaria AL Colao, Prof. (1)  ·  Asma A Salam, MCPS, FCPS (1)  ·  Bing Xing, MD (1)  ·  Daniel F Kelly, MD (1)  ·  David M Kleinberg, MD (1)  ·  Dawid Schellingerhout (1)  ·  Dileep Kumar, MBBS, FCPS (1)

Results publications

PMID 10469005, PMID 10690849, PMID 10999798, PMID 11397887, PMID 12843148, PMID 14764779, PMID 15070920, PMID 15613435, PMID 15827109, PMID 15886238, PMID 15886256, PMID 16373932, PMID 16449332, PMID 16487447, PMID 16537687, PMID 17984237, PMID 19306364, PMID 19564304, PMID 21319349, PMID 21909835, PMID 25293480, PMID 25493927, PMID 26229757, PMID 26329913, PMID 28298041, PMID 28756607, PMID 29151054, PMID 30010438, PMID 35275019, PMID 35661809, PMID 36239858, PMID 37013278, PMID 38553990, PMID 3899825, PMID 40760415, PMID 42046793, PMID 5427331, PMID 8050136, PMID 8327647, PMID 8514973, PMID 9709939, PMID 9768640, PMID 9768641, PMID 9808008

NIH funding

2023 (1), P30CA021765 (1), P30CA033572 (1), R01CA078957 (1), U01CA081445 (1)